Search research articles
Contact Us
Filters
Showing results (421-430 of 458) with videos related to
Page
of 46
Sort By:
Clinical Pharmacology and Therapeutics
|
August 1, 1991
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers
M Burnier, M Ganslmayer, F Perret, et al.
Fundamental & Clinical Pharmacology
|
January 1, 1988
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers
J Bidiville, G Waeber, M Porchet, et al.
Journal of Hypertension
|
January 1, 1993
Isobaric compliance of the radial artery is increased in patients with essential hypertension
S Laurent, D Hayoz, S Trazzi, et al.
Placenta
|
July 22, 2014
High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?
P-A Pradervand, S Clerc, J Frantz, et al.
Kidney International. Supplement
|
October 1, 1988
Role of endogenous bradykinin in blood pressure control of conscious rats
B Waeber, J F Aubert, J P Flückiger, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1992
Conduit artery compliance and distensibility are not necessarily reduced in hypertension
D Hayoz, B Rutschmann, F Perret, et al.
Elife
|
June 28, 2021
Structure and mechanistic features of the prokaryotic minimal RNase P
Rebecca Feyh, Nadine B Waeber, Simone Prinz, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1988
Infusion of atrial natriuretic peptide to patients with congestive heart failure
J J Goy, B Waeber, J Nussberger, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow
J Biollaz, B Waeber, J Nussberger, et al.
The American Journal of Cardiology
|
April 1, 1985
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure
P Nicod, B Waeber, J P Bussien, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 458) with videos related to
Sort By:
Page
of 46
Clinical Pharmacology and Therapeutics
|
August 1, 1991
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers
M Burnier, M Ganslmayer, F Perret, et al.
Fundamental & Clinical Pharmacology
|
January 1, 1988
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers
J Bidiville, G Waeber, M Porchet, et al.
Journal of Hypertension
|
January 1, 1993
Isobaric compliance of the radial artery is increased in patients with essential hypertension
S Laurent, D Hayoz, S Trazzi, et al.
Placenta
|
July 22, 2014
High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?
P-A Pradervand, S Clerc, J Frantz, et al.
Kidney International. Supplement
|
October 1, 1988
Role of endogenous bradykinin in blood pressure control of conscious rats
B Waeber, J F Aubert, J P Flückiger, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 1, 1992
Conduit artery compliance and distensibility are not necessarily reduced in hypertension
D Hayoz, B Rutschmann, F Perret, et al.
Elife
|
June 28, 2021
Structure and mechanistic features of the prokaryotic minimal RNase P
Rebecca Feyh, Nadine B Waeber, Simone Prinz, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1988
Infusion of atrial natriuretic peptide to patients with congestive heart failure
J J Goy, B Waeber, J Nussberger, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow
J Biollaz, B Waeber, J Nussberger, et al.
The American Journal of Cardiology
|
April 1, 1985
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure
P Nicod, B Waeber, J P Bussien, et al.
Page
of 46